Sakar Healthcare
332.35
-8.60(-2.52%)
Market Cap₹729.51 Cr
PE Ratio38.31
IndustryHealthcare
Company Performance:
1D-2.52%
1M-1.96%
6M+22.30%
1Y+3.54%
5Y+379.93%
View Company Insightsright
Latest news about Sakar Healthcare
Sakar Healthcare Reports 95% Surge in Q1 Net Profit, EBITDA Grows Despite Margin Decline Jul 25, 2025
Sakar Healthcare Ltd. announced impressive Q1 results with net profit soaring 95% to ₹46.70 million from ₹24.00 million year-over-year. EBITDA grew 18.7% to ₹127.00 million, although EBITDA margin slightly decreased to 24.1% from 26.0%. The company demonstrated strong profitability growth despite some margin pressure, indicating effective cost management and possibly a favorable product mix.
Sakar Healthcare Expands European Footprint with New Anti-Cancer Injection Approvals Jul 16, 2025
Sakar Healthcare Eyes EU Expansion with Anticipated MAS Approval for Oncology Products Jun 18, 2025
Sakar Healthcare Reports Impressive Q4 FY23 Results with Substantial Profit Growth May 15, 2025
Sakar Healthcare Achieves First EU Marketing Authorization for Oncology Injection Apr 21, 2025
More news about Sakar Healthcare
16Apr 25
Sakar Healthcare Expands Global Reach with 9 New Export Agreements
Sakar Healthcare Ltd has signed nine strategic agreements with partners in Europe and South America for exporting oncology products. This move marks a significant step in the company's global expansion strategy, particularly in the oncology segment. While financial details are undisclosed, the partnerships are expected to boost export volumes and revenue, diversify market presence, and strengthen the company's position in the specialized pharmaceutical market.
Sakar Healthcare
332.35
-8.60
(-2.52%)
1 Year Returns:+3.54%
Industry Peers
Sun Pharmaceutical
1,593.60
(+0.71%)
Divis Laboratories
6,009.00
(-2.03%)
Cipla
1,553.40
(-1.55%)
Torrent Pharmaceuticals
3,579.10
(-0.56%)
Dr Reddys Laboratories
1,268.10
(+1.21%)
Mankind Pharma
2,550.60
(-0.71%)
Zydus Life Science
1,013.85
(+0.19%)
Lupin
1,943.90
(+0.24%)
Abbott
31,150.00
(-3.19%)
Alkem Laboratories
5,333.50
(+0.60%)